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INTRODUCTION:  Emphysematous  gastritis  is a  rare condition  in  which  gas  accumulates  in the  stomach
lining  usually  due  to  an  infectious  source.
CASE  PRESENTATION:  We  present  a 16 year  old female  with  viral  myocarditis  and  cardiogenic  shock  trans-
ferred to  our  hospital  on extracorporeal  membrane  oxygenation  (ECMO)  who  developed  emphysematous
gastritis.  After listing  the  patient  for heart  transplant,  patient  underwent  Bi-VAD  placement  requir-
ing  veno-venous  ECMO  support.  Subsequently,  she  developed  worsening  abdominal  distention.  CT of
abdomen/pelvis  showed  the  stomach  to be diffusely  edematous,  thick-walled,  containing  intramural  gas
collections,  consistent  with  emphysematous  gastritis.  Patient  underwent  nonoperative  management  and
two weeks  later  had  complete  resolution  of  the  gastritis.  Unfortunately,  her  overall  condition  deteriorated
in  the  subsequent  days  and support  was  withdrawn.
DISCUSSION:  Management  of emphysematous  gastritis  usually  revolves  around  supportive  care,  broad
spectrum  antibiotics  and  bowel  rest.  Our patients’  gastritis  resolved  with  non-operative  management,
albeit,  she  succumbed  to  multiorgan  failure  due  to other causes.
CONCLUSION:  We  believe,  this  is  a unique  case  of a  veno-arterial  ECMO  causing  emphysematous  gastritis.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Background
Emphysematous gastritis is an extremely rare condition in
which gas accumulates in the stomach lining secondary to infec-
tion with gas-producing organisms. It is often associated with
high mortality, and surgical intervention is usually avoided unless
uncontrollable sepsis persists or patient develops gastric perfo-
ration. We  present the case of a 16 year old female with viral
myocarditis and cardiogenic shock that was transferred to our
hospital on extracorporeal membrane oxygenation and developed
emphysematous gastritis that resolved with nonoperative manage-
ment.
2. Case presentation
The patient is a 16 year old female, otherwise healthy, who  pre-
sented to an outside hospital with a one week history of fever, chest
and back pain. On initial workup, she was found to have ST elevation
in all leads with troponin of 98 ng/L. Soon after, she became hemo-
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dynamically unstable, in cardiogenic shock and respiratory failure
requiring intubation and vasopressors. This was complicated by
ventricular tachycardia. Lidocaine was  administered and patient’s
rhythm was  brought back. However, she continued to deteriorate
and it was decided to place her on venoarterial extracorporeal
membrane oxygenation (VA-ECMO) via right internal jugular vein
into her right femoral vein and femoral artery. A myocardial
biopsy was performed that revealed lymphocytic inﬁltrate. The
patient received high dose solumedrol with no improvement in
her symptomatology. Echocardiogram revealed severe biventricu-
lar dysfunction with biventricular akinesis. Her blood and urine
cultures were negative. Our hospital was consulted for possible
bridge to recovery and transplant evaluation. On arrival to our
hospital, patient stayed intubated with VA-ECMO circuit in place.
She was awake and intermittently following commands. Her mean
blood pressure was  77 mmHg  with no systolic or diastolic compo-
nent with warm and pulseless extremities. Rest of the examination
was unremarkable. She was on milrinone, nipride, furosemide,
and heparin infusions. Her initial labs revealed hemoglobin and
hematocrit of 11 g/dL and 33%, white count of 10.4 × 10(9)/L,
platelets 89 × 10(9)/L, creatinine 1.2 mg/dL and bilirubin 1.1 mg/dL.
A repeat electrocardiogram revealed asystole and echocardiogram
performed at our hospital revealed dense “jello like” soft tissue
echoes in the left ventricle extending upto the aortic valve consis-
http://dx.doi.org/10.1016/j.ijscr.2015.06.045
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Fig. 1. Gaseous distention of the stomach as well as dilated small bowel measuring
5 cm in caliber.
tent with thrombotic stasis. Similar ﬁndings were seen in the right
ventricle. Initial computed tomography (CT) of chest, abdomen and
pelvis had extensive consolidation in the lower lobes with small
bilateral pleural effusions and pericardial effusions, with moder-
ate ascites in abdomen and pelvis, edematous gallbladder, and no
evidence of bowel obstruction. The stomach was pathologically
normal on review of initial work-up.
After patient was evaluated and listed for heart transplantation,
she was taken to the operating room for placement of Thoratec
biventricular assist device (Bi-VAD). Once the Bi-VAD was allowed
to take over the circulation, patient became hypoxic with weaning
off cardiopulmonary bypass, and the decision was made to place the
patient on veno-venous ECMO (VV-ECMO). The femoral artery can-
nula was removed and repaired. The right femoral vein cannula was
used as the inﬂow, and the right internal jugular cannula was  used
as the outﬂow for the ECMO circuit. Left ventricular biopsy revealed
severe lymphocytic inﬁltrate with marked myocyte necrosis. There
were no giant cells, eosinophils, or evidence of vasculitis. Additional
studies on the myocardium involving polymerase chain reaction
and in-situ hybridization showed active replication of coxsackie
B3 virus.
Few days later, patients urine output continued to decline with
increase in creatinine upto 2.6 mg/dL. She was diagnosed with acute
kidney injury secondary to her critically ill state by nephrology
and they recommended continuous renal replacement therapy. She
developed hemorrhagic pulmonary edema and after bronchoscopy
she was found to be positive for Escherichia coli. The next day patient
was found to have massive abdominal distention with liquid non-
bloody stools. Abdominal X-ray revealed gaseous distention of the
stomach (Fig. 1) as well as small bowel measuring up to 5 cm in
caliber, ﬁnding consistent with small bowel obstruction/ileus. A CT
of abdomen and pelvis showed stomach to be diffusely edematous,
thick-walled, containing intramural gas collections, consistent with
emphysematous gastritis (Fig. 2). Small bowel was  found to have
thickened valvulae conniventes but appeared to perfusing nor-
mally. A subsequent echocardiogram demonstrated good pulsatile
LVAD inﬂow with a velocity of 2.23 m/s  and outﬂow with a velocity
Fig. 2. Stomach is diffusely edematous and thick-walled and contains both linear
and rounded intramural gas collections consistent with emphysematous gastritis.
of 2.4 m/s. RVAD inﬂow had a velocity of 1.6 m/s  with outﬂow of
1.2 m/s. Severe decrease in left and right ventricular function were
also seen, as expected. There was  no mass/thrombus visualized in
the left atrium. Following this, patient was kept NPO, on nasogas-
tric tube decompression, on broad spectrum antibiotics, including
vancomycin, meropenem and ﬂuconcazole; and aggressive resus-
citation involving multiple vasopressors was continued.
Two weeks later, patient was  found to have complete resolution
of emphysematous gastritis with return of stomach wall thick-
ness to normal [Fig. 3]. Normal caliber loops of small and large
bowel were found with easy transit of oral contrast into the colon.
However, patient continued to be in progressive respiratory failure
requiring ECMO support for which she underwent right mini tho-
racotomy and open lung biopsy. Pathology revealed hemorrhagic
diffuse acute lung injury with features most consistent with hem-
orrhagic diffuse alveolar damage. Additional stains were performed
on the specimen to rule out viral cause, all of which were negative.
Patient continued to be in multisystem organ failure with persis-
tent elevation in liver function tests involving ALT of 329 IU, AST of
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Fig. 3. Resolution of the gas collections and gaseous distention of the stomach.
692 IU, Alkphos of 362 IU and total bilirubin of 30.2 mg/dL. Patient
underwent a repeat viral serology screen at which point she had
a positive CMV  serology of greater than 60 and PCR which con-
ﬁrmed the presence of disseminated CMV  for which ganciclovir
was started.
Hepatology was consulted who recommended a transjugu-
lar liver biopsy. Pathology revealed severe hepatocanalicular and
cholangiolar cholestasis with centrilobular feathery degeneration
and focal central lobular hepatocyte dropout, consistent with
nonobstructive cholestatic process. However, CMV  immunohisto-
chemical stain was negative.
In the next few days, patient continued to deteriorate hemo-
dynamically with increasing norepinephrine requirements as high
as 24 mcg/min. Due to the patient’s now hypercapnic and hypoxic
respiratory failure, oliguric renal failure, shock liver, biventricu-
lar systolic failureon biventricular assist devices, with persistent
E. coli pneumonia, CMV  viremia, coxsackie B myocarditis, superﬁ-
cial dehiscence of most of the surgical wounds, a family meeting
was done. The patient was not a candidate for heart/lung trans-
plant or ECMO at this point. No more escalation of therapy was
decidedand the family agreed for withdrawal of support.
3. Discussion
Emphysematous gastritis is a rare, potentially fatal condition,
ﬁrst described in 1889 [1]. It usually presents with abdominal pain,
nausea, emesis and ﬂorid septic shock, with a mortality rate of
55–61% [2–3]. Diagnosis is usually made based on a CT scan which
typically shows gastric wall thickening and intramural gas [4–5].
The gas pattern is more prominent around the fundus and the
greater curvature as described before [4].
Several etiologies have been reported such as vessel occlusion,
gastric infarction or gastric volvulus. However, rarely, it has also
been associated with nasogastric tube placement, persistent eme-
sis, severe gastroenteritis, especially following chemotherapy or
related to gastric ulcer disease. Gastric pneumatosis may  also occur
after caustic ingestion, excessive ingestion of carbonated bever-
ages, iatrogenis injury or sometime even idiopathic [6].
There are a number of predisposing factors that have been iden-
tiﬁed: immunosuppression including diabetes, malignancy, alco-
hol, medication abuse (especially non-steroidal anti-inﬂammatory
drugs), post abdominal/pelvic surgery and corrosive ingestion
[7–10]. Usually causative organisms can include Gram positive
cocci, Gram negative rod (E. coli) and sometimes even fungi (Can-
dida albicans) [4,5,11]. However, there has been no association
reported in the literature with viral dissemination, either Cox-
sackie virus or CMV. Our patient presented to us as a result of
viral myocarditis and subsequently deteriorated. It is difﬁcult to
ascertain viral organisms playing a direct role as they are not gas
forming. However, in the setting of extreme ill state with relative
immunosuppression, it may  be reasonable to assume, that this lead
to concomitant bacterial invasion of the gastric lining.
Furthermore, our patient did not have a nasogastric tube
inserted before the event and nor did she have an infectious
diarrhea. She began to have liquid non-bloody stools when she
developed abdominal distention but stool studies did not reveal
any organism. It may  be possible that she harboured an ulcer but
resolution of the ﬁndings with just nonoperative management does
not favour that. In one of the series [6], only 38% of the patients
had a portal venous air present. On further analysis, there was no
signiﬁcant difference observed in patients that survived and those
that did not. Even though, it is considered a hallmark sign of pneu-
matosis, whether small bowel, colonic or even stomach related, the
absence of portal gas does not rule it out and caution should always
be exercised.
Another possibility is the relative low-ﬂow state that was
present in our patient. Even though, the patient was supported
using VA-ECMO and was  transitioned to Bi-VAD, the ongoing sep-
sis proved it extremely difﬁcult to maintain adequate ﬂows to
achieve good perfusion. This could have potentially lead to bac-
terial translocation of the gastrointestinal tract that resulted in
emphysematous gastritis. Why  this would affect the stomach more
so than small or large bowel, is unclear. It is also interesting that
despite her worsening overall hemodynamic instability, her gas-
tric emphysema did get better and eventually resolved. One could
argue that even with her low ﬂow state, the appropriate use of
antibiotics along with bowel rest gave her gastric mucosa enough
time to recover and avoid a perforated viscus. To our knowledge,
there has been no reported case of such a condition in patient with
ECMO. With increasing use of this technology, it is only possible
that we  may  see more of this in the future.
Management of emphysematous gastritis usually revolves
around supportive care, broad spectrum antibiotics and bowel rest
[12,13]. The mortality due to surgical intervention can be as high
as 21% [12] and usually reserved for cases with refractory medi-
cal management, uncontrollable sepsis, or perforated viscus [14].
Our patients’ gastritis resolved with non-operative management,
albeit, she succumbed to multiorgan failure due to other causes.
4. Conclusion
Emphysematous gastritis is a potentially fatal condition. If diag-
nosed early, it can be managed with supportive care with surgery
reserved for refractory cases. We  believe our patient is a unique
case of a veno-arterial ECMO causing emphysematous gastritis.
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